192 related articles for article (PubMed ID: 29369166)
21. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
23. Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial.
Fujisue K; Nagamatsu S; Shimomura H; Yamashita T; Nakao K; Nakamura S; Ishihara M; Matsui K; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Sakamoto K; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
Int J Cardiol; 2018 Oct; 268():23-26. PubMed ID: 29925472
[TBL] [Abstract][Full Text] [Related]
24. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
Kolossváry M; deFilippi C; Lu MT; Zanni MV; Fulda ES; Foldyna B; Ribaudo H; Mayrhofer T; Collier AC; Bloomfield GS; Fichtenbaum C; Overton ET; Aberg JA; Currier J; Fitch KV; Douglas PS; Grinspoon SK
J Infect Dis; 2022 Nov; 226(10):1809-1822. PubMed ID: 35535576
[TBL] [Abstract][Full Text] [Related]
25. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study.
Zeb I; Li D; Nasir K; Malpeso J; Batool A; Flores F; Dailing C; Karlsberg RP; Budoff M
Atherosclerosis; 2013 Dec; 231(2):198-204. PubMed ID: 24267226
[TBL] [Abstract][Full Text] [Related]
26. Medical Therapy Induced Regression of Plaque in a Female Patient with ASCVD.
Guan S; Zhang Y; Wang B; Li W
Int Heart J; 2019 Jan; 60(1):175-177. PubMed ID: 30464115
[TBL] [Abstract][Full Text] [Related]
27. [Effects of statins on coronary atherosclerotic plaque in patients with coronary heart disease and type 2 diabetes with mild elevated LDL-C].
Wang XF; Lu CZ; Chen X
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):339-42. PubMed ID: 19791470
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
[TBL] [Abstract][Full Text] [Related]
29. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
[TBL] [Abstract][Full Text] [Related]
30. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA
Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195
[TBL] [Abstract][Full Text] [Related]
31. Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging: The AQUAMARINE Pilot Study.
Noguchi T; Tanaka A; Kawasaki T; Goto Y; Morita Y; Asaumi Y; Nakao K; Fujiwara R; Nishimura K; Miyamoto Y; Ishihara M; Ogawa H; Koga N; Narula J; Yasuda S
J Am Coll Cardiol; 2015 Jul; 66(3):245-256. PubMed ID: 26184618
[TBL] [Abstract][Full Text] [Related]
32. Influence of achieved low-density lipoprotein cholesterol level with atorvastatin therapy on stabilization of coronary plaques: sub-analysis of the TWINS study.
Okada K; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
Circ J; 2012; 76(5):1197-202. PubMed ID: 22343194
[TBL] [Abstract][Full Text] [Related]
33. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography.
Mitsutake R; Miura S; Okamura K; Niimura H; Kawamura A; Saku K
Intern Med; 2007; 46(12):859-63. PubMed ID: 17575379
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
Rodés-Cabau J; Tardif JC; Cossette M; Bertrand OF; Ibrahim R; Larose E; Grégoire J; L'allier PL; Guertin MC
Am J Cardiol; 2009 Sep; 104(6):750-7. PubMed ID: 19733706
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
Longenecker CT; Sattar A; Gilkeson R; McComsey GA
AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
[TBL] [Abstract][Full Text] [Related]
36. HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.
Hale AT; Longenecker CT; Jiang Y; Debanne SM; Labatto DE; Storer N; Hamik A; McComsey GA
AIDS; 2015 Aug; 29(13):1643-50. PubMed ID: 26372274
[TBL] [Abstract][Full Text] [Related]
37. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
[TBL] [Abstract][Full Text] [Related]
39. Relation of response of subclinical atherosclerosis detected by electron beam tomography to baseline low-density lipoprotein cholesterol levels.
Hecht HS; Harman SM
Am J Cardiol; 2004 Jan; 93(1):101-3. PubMed ID: 14697479
[TBL] [Abstract][Full Text] [Related]
40. Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.
Looby SE; Fitch KV; Srinivasa S; Lo J; Rafferty D; Martin A; Currier JC; Grinspoon S; Zanni MV
AIDS; 2016 Jan; 30(3):383-93. PubMed ID: 26696388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
